Hypha Discovery and Cypex announce a partnership
February 3, 2020 5:40 pm Leave your thoughtsAs a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the...
View Article
As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the...
View Article
We are excited to announce the official launch of our One-Stop Metabolite Shop, which offers a complete solution for pharma...
View Article
Hypha are looking forward to presenting two posters at the ISSX meeting held in Portland US from 28th to 31st...
View Article
Our newsletter this quarter looks at the use of microbial biotransformation to synthesize glucuronide metabolites, with a particular emphasis on...
View Article
Hypha are excited to present a poster describing the application of PolyCYPs enzyme kits to create oxidised derivatives of drug...
View Article
We have just published an article on “Accessing Difficult-to-Synthesise Metabolites in Drug Development Programmes” in the April 2019 edition of...
View Article
22nd January, 2019 Hypha are pleased to announce the official launch of their PolyCYPs® kit, which provide a fast and...
View Article
Hypha are delighted to announce the appointment of Lisbet Kvaerno PhD as Head of Synthetic Chemistry at Hypha. Lisbet has...
View Article
We are pleased that a paper by Salter et al., 2018 has been published in Xenobiotica. The paper, entitled Microbial...
View Article
A 2018 Nature Reviews Drug Discovery paper by Bostrom et al on “Expanding the medicinal chemistry synthetic toolbox” features examples...
View Article